Asthma: NICE recommends LTRA tablets over combination inhaler

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • The new NICE draft guideline on asthma management currently under consultation recommends leukotriene receptor antagonist (LTRA) tablets over combination inhaler therapy in a move to boost savings for the NHS.

Key highlights

  • Newly diagnosed patients with asthma should be offered a short-acting beta2 agonist (SABA) to relieve symptoms as and when they occur.
  • A low-dose inhaled corticosteroid (ICS) is suitable as maintenance therapy for patients with symptoms uncontrolled by SABA.
  • If symptoms remain uncontrolled with ICS, patients should be offered an LTRA along with ICS before considering the combination (LABA + ICS)...